Search results
Results From The WOW.Com Content Network
Rotarix (human rotavirus vaccine, live attenuated) Shingrix (for Zoster Vaccine Recombinant, Adjuvanted) Synflorix (pneumococcal polysaccharide conjugate vaccine (adsorbed)) Twinrix (for combined hepatitis A (inactivated virus) and hepatitis B vaccine (genetically derived surface antigen)) Typherix (typhoid vaccine (purified polysaccharide ...
Pages in category "Drugs developed by GSK plc" The following 162 pages are in this category, out of 162 total. This list may not reflect recent changes. ...
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
It is a key element of CEO Emma Walmsley's push to enhance investor confidence in the strength of GSK's drug development pipeline. Cabenuva sales more than doubled to 708 million pounds last year ...
The drug, part of GSK's infectious diseases portfolio, is among the product launches poised to boost future growth and restore investor confidence in the company's medicines pipeline post the spin ...
-GSK on Thursday lifted its medium-term growth forecast for its HIV drugs business ViiV, encouraged by strong sales of long-acting injections that aim to replace daily pills for preventing and ...
Elinzanetant. Elinzanetant (developmental code names BAY-3427080 GSK-1144814, NT-814) is an orally active small-molecule neurokinin/tachykinin NK 1 receptor and NK 3 receptor antagonist which is under development by Bayer, GlaxoSmithKline, and NeRRe Therapeutics for the treatment of hot flashes and "sex hormone disorders". [1] [2] It has been ...
May 21, 2024 at 2:29 AM. (Reuters) -GSK's experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker ...